List Title | APhA DrugInfoLine

Focus on Asthma Care

SORT BY: Most Recent Most Viewed

December 3, 2018

SMART therapy associated with a lower risk of asthma exacerbations

READ

PREVIEW
A meta-analysis of 16 trials evaluating use of a single maintenance and reliever therapy (SMART), with the majority of studies using a combination of budesonide and formoterol in a dry-powder...
May 1, 2018

Increasing inhaled glucocorticoid doses to prevent asthma exacerbations

READ

PREVIEW
In children with moderate to severe persistent asthma, quintupling the inhaled corticosteroid (ICS) dose at early signs of loss of asthma control did not reduce the rate of severe asthma...
March 20, 2018

New recommendations on allergic rhinitis

READ

PREVIEW
An updated guideline for pharmacological treatment of seasonal allergic rhinitis recommends monotherapy with an intranasal (I.N.) corticosteroid over combination therapy with an I.N....
November 14, 2017

Azithromycin use improves outcomes in patients with persistent asthma

READ

PREVIEW
Use of azithromycin 500 mg three times per week as an add-on therapy to long-term controller medications in patients with uncontrolled persistent asthma resulted in fewer asthma exacerbations and...
July 10, 2017

Combination beta agonists and anticholinergics better than beta agonists alone for acute asthma

READ

PREVIEW
A Cochrane systematic review concluded that combination therapy with a short-acting beta agonist (SABA) and a short-acting anticholinergic (SAAC) was more effective at reducing the rate of...

Pages

Medication Monitor

RSS Follow Medication Monitor on Twitter Follow APhA Druginfoline on Twitter

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.